Estados Unidos · Bolsa y Finanzas · Forbes

Reimbursement For Multi-Cancer Early Detection Tests Faces Uncertainty

Publicado por Forbes · Estados Unidos hace 13 h

Given what some experts and clinicians cite as a lack of clear evidentiary benefit, FDA approval doesn’t guarantee reimbursement of multi-cancer early detection tests.

Leer el artículo completo en Forbes Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.forbes.com)

Reimbursement For Multi-Cancer Early Detection Tests Faces Uncertainty

También te puede interesar

‘Digger,’ Warner Bros.’ Last Release Before Merger, Is a Major Flop

Trump taps Director of National Intelligence Jay Clayton as AI czar: WSJ reports

The Iran War Is Showing What ADNOC’s AI Can Really Do

Mormon leader decries explosion of gambling and blasts prediction market wagers — ‘Or even, if you can imagine, the timing of the Second Coming’

Scott Bessent compares AI CEOs who warn of catastrophe to Hannibal Lecter: 'Stop me before I kill again'

Federal judge calls Flock ‘indiscriminate mass surveillance’

Reimbursement For Multi-Cancer Early Detection Tests Faces Uncertainty

Compartir

También te puede interesar

‘Digger,’ Warner Bros.’ Last Release Before Merger, Is a Major Flop

Trump taps Director of National Intelligence Jay Clayton as AI czar: WSJ reports

The Iran War Is Showing What ADNOC’s AI Can Really Do

Mormon leader decries explosion of gambling and blasts prediction market wagers — ‘Or even, if you can imagine, the timing of the Second Coming’

Scott Bessent compares AI CEOs who warn of catastrophe to Hannibal Lecter: 'Stop me before I kill again'

Federal judge calls Flock ‘indiscriminate mass surveillance’